6,780 RSUs granted to TransAct Technologies (TACT) chief accounting officer

Rhea-AI Filing Summary

TransAct Technologies reported that Chief Accounting Officer William DeFrances received a grant of 6,780 Restricted Stock Units on February 25, 2026. These RSUs were issued under the company’s 2014 Equity Incentive Plan, as Amended and Restated.

The award cliff vests on the second anniversary of the grant date and then converts into common stock on a one-for-one basis, aligning the executive’s compensation with future company performance. Following these transactions, his directly held common stock balance is reported as zero shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider DEFRANCES WILLIAM

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	6,780	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 6,780 shares (Direct); Common Stock — 0 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

DEFRANCES WILLIAM

(Last) (First) (Middle)

2319 WHITNEY AVENUE

(Street)

HAMDEN CT 06518

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
TRANSACT TECHNOLOGIES INC [ TACT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/25/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/25/2026		A		6,780		(1)	(1)	Common Stock	6,780	$0(1)	6,780	D

Explanation of Responses:

1. Restricted Stock Units issued on February 25, 2026 pursuant to the Company's 2014 Equity Incentive Plan, as Amended and Restated, cliff vesting on the second anniversary date of the grant and converting to common stock on a one-for-one basis.

	William DeFrances	02/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did TransAct Technologies (TACT) disclose about William DeFrances in this Form 4?

The filing shows Chief Accounting Officer William DeFrances received 6,780 Restricted Stock Units on February 25, 2026. These units were granted under TransAct Technologies’ 2014 Equity Incentive Plan, reinforcing equity-based executive compensation tied to the company’s future performance.

How many Restricted Stock Units were granted to the TACT Chief Accounting Officer?

William DeFrances was granted 6,780 Restricted Stock Units. The award was issued at a price of $0.00 per unit as compensation, not a market purchase, and forms part of his equity incentives at TransAct Technologies under the 2014 Equity Incentive Plan.

When do the new TACT Restricted Stock Units for William DeFrances vest?

The 6,780 Restricted Stock Units cliff vest on the second anniversary of the February 25, 2026 grant date. This means none vest before that time, encouraging longer-term retention and alignment with TransAct Technologies’ multi-year performance goals.

How will the granted RSUs convert into TransAct Technologies common stock?

Upon vesting, each Restricted Stock Unit converts into one share of TransAct Technologies common stock. The conversion ratio is one-for-one, so the 6,780 RSUs can become up to 6,780 common shares if fully vested and settled in stock.

What does the Form 4 say about William DeFrances’ common stock holdings after this grant?

After the reported transactions, William DeFrances’ directly held common stock balance is listed as zero shares. His equity exposure at TransAct Technologies is therefore currently through the 6,780 unvested Restricted Stock Units granted on February 25, 2026.

Under which plan were the TACT RSUs for William DeFrances issued?

The 6,780 Restricted Stock Units were issued under TransAct Technologies’ 2014 Equity Incentive Plan, as Amended and Restated. This plan governs equity awards to employees and executives, providing stock-based incentives linked to the company’s long-term performance.